BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22056226)

  • 1. Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis.
    Wang J; Welch K; Wang L; Kong FM
    Clin Lung Cancer; 2012 Mar; 13(2):81-9. PubMed ID: 22056226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy.
    Akthar AS; Ferguson MK; Koshy M; Vigneswaran WT; Malik R
    Technol Cancer Res Treat; 2017 Feb; 16(1):15-21. PubMed ID: 26792491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N2 disease in T1 non-small cell lung cancer.
    Defranchi SA; Cassivi SD; Nichols FC; Allen MS; Shen KR; Deschamps C; Wigle DA
    Ann Thorac Surg; 2009 Sep; 88(3):924-8. PubMed ID: 19699921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of positron emission tomography in the management of non-small cell lung cancer.
    Behzadi A; Ung Y; Lowe V; Deschamps C
    Can J Surg; 2009 Jun; 52(3):235-42. PubMed ID: 19503669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.
    Schmidt-Hansen M; Baldwin DR; Hasler E; Zamora J; Abraira V; Roqué I Figuls M
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009519. PubMed ID: 25393718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.
    De Leyn P; Dooms C; Kuzdzal J; Lardinois D; Passlick B; Rami-Porta R; Turna A; Van Schil P; Venuta F; Waller D; Weder W; Zielinski M
    Eur J Cardiothorac Surg; 2014 May; 45(5):787-98. PubMed ID: 24578407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Silvestri GA; Gonzalez AV; Jantz MA; Margolis ML; Gould MK; Tanoue LT; Harris LJ; Detterbeck FC
    Chest; 2013 May; 143(5 Suppl):e211S-e250S. PubMed ID: 23649440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?
    Wu LM; Xu JR; Gu HY; Hua J; Chen J; Zhang W; Haacke EM; Hu J
    J Surg Res; 2012 Nov; 178(1):304-14. PubMed ID: 22541065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal
    Zuo Y; Liu Q; Li N; Li P; Zhang J; Song S
    Front Oncol; 2023; 13():1173355. PubMed ID: 37223682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study.
    Hosny A; Parmar C; Coroller TP; Grossmann P; Zeleznik R; Kumar A; Bussink J; Gillies RJ; Mak RH; Aerts HJWL
    PLoS Med; 2018 Nov; 15(11):e1002711. PubMed ID: 30500819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.
    Aerts HJ; Velazquez ER; Leijenaar RT; Parmar C; Grossmann P; Carvalho S; Bussink J; Monshouwer R; Haibe-Kains B; Rietveld D; Hoebers F; Rietbergen MM; Leemans CR; Dekker A; Quackenbush J; Gillies RJ; Lambin P
    Nat Commun; 2014 Jun; 5():4006. PubMed ID: 24892406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies.
    Dong Y; Zhou H; Alhaskawi A; Wang Z; Lai J; Yao C; Liu Z; Hasan Abdullah Ezzi S; Goutham Kota V; Hasan Abdulla Hasan Abdulla M; Lu H
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [
    Rogasch JMM; Michaels L; Baumgärtner GL; Frost N; Rückert JC; Neudecker J; Ochsenreither S; Gerhold M; Schmidt B; Schneider P; Amthauer H; Furth C; Penzkofer T
    Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2140-2151. PubMed ID: 36820890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of pyruvate dehydrogenase-E1α expression to determine SUVmax cut-off value of [
    Ito R; Yashiro M; Tsukioka T; Izumi N; Komatsu H; Inoue H; Nishiyama N
    Sci Rep; 2023 Jan; 13(1):1565. PubMed ID: 36709375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined procedure with radial probe and convex probe endobronchial ultrasound.
    Chung HS; Pak K; Lee G; Eom JS
    Thorac Cancer; 2022 Oct; 13(20):2837-2843. PubMed ID: 36054540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes.
    Habermann FOJ; Schmitt D; Failing T; Fischer J; Ziegler DA; Fischer LA; Alt NJ; Muster J; Donath S; Hille A; Schirmer MA; Guhlich M; El Shafie RA; Rieken S; Leu M; Dröge LH
    Curr Oncol; 2022 Feb; 29(2):1080-1092. PubMed ID: 35200591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endobronchial ultrasound-guided transbronchial needle aspiration in staging of lung cancer: a thoracic surgeon's perspective.
    Melloni G; Mazza F; Venturino M; Turello D
    Mediastinum; 2021; 5():2. PubMed ID: 35118308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.